A group of major pharmaceutical companies, including AbbVie, Bristol-Myers Squibb, Amgen, Pfizer, Moderna, and Merck, are noted as peers operating in the highly regulated pharmaceutical sector.
Steady: 0 in the last 7 days
Updated oct 11
The latest in this situation
How it started
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A group of major pharmaceutical companies, including AbbVie, Bristol-Myers Squibb, Amgen, Pfizer, Moderna, and Merck, are noted as peers operating in the highly regulated pharmaceutical sector.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Major pharmaceutical companies are competing for investment capital.Sub-event
Major pharmaceutical companies are noted as peers in the regulated industry.1 source
Keep exploring
The entities involved
-
AbbVie
pharmaceutical company
-
Bristol-Myers Squibb
American pharmaceutical company
-
Amgen
American multinational biopharmaceutical company
-
Pfizer
American multinational pharmaceutical and biotechnology corporation
Related events
- Bristol-Myers Squibb and AbbVie secured regulatory approval for a therapy in the US.
- AbbVie, Eli Lilly, and Merck are broadening their therapeutic reach.
- AbbVie and others are managing drug exclusivity, seeking next-gen immunology pipeline growth, and competing for market share.
- AbbVie and Abbott Laboratories are large healthcare companies whose corporate histories are linked by a major split that occurred in 2013.
- AbbVie, Johnson & Johnson, Bristol-Myers Squibb, and Amgen are innovating targeted, cost-effective therapies for psoriatic arthritis.